位置:首页 > 蛋白库 > THMS2_HUMAN
THMS2_HUMAN
ID   THMS2_HUMAN             Reviewed;         643 AA.
AC   Q5TEJ8; A2RTZ3; B4DZT9; B4DZY3; O60560; Q5TEJ1; Q5TEJ9; Q5TEK1; Q68DP4;
AC   Q9BYB6; Q9NS90;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   03-AUG-2022, entry version 130.
DE   RecName: Full=Protein THEMIS2 {ECO:0000305};
DE   AltName: Full=Induced by contact to basement membrane 1 protein {ECO:0000303|PubMed:20644716};
DE            Short=Protein ICB-1;
DE   AltName: Full=Thymocyte-expressed molecule involved in selection protein 2;
GN   Name=THEMIS2 {ECO:0000312|HGNC:HGNC:16839};
GN   Synonyms=C1orf38, ICB1 {ECO:0000303|PubMed:20644716};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 4-643 (ISOFORM 5), AND VARIANT GLU-511.
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 112-643 (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Endometrial adenocarcinoma;
RX   PubMed=9563507; DOI=10.1016/s0014-5793(98)00278-6;
RA   Treeck O., Strunck E., Vollmer G.;
RT   "A novel basement membrane-induced gene identified in the human endometrial
RT   adenocarcinoma cell line HEC1B.";
RL   FEBS Lett. 425:426-430(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 112-643 (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 143-643 (ISOFORM 2), AND VARIANT GLU-511.
RC   TISSUE=Leukocyte;
RA   Tanaka K., Imai H., Odani T., Tachibana M., Fujita S.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION.
RX   PubMed=20644716; DOI=10.1371/journal.pone.0011465;
RA   Peirce M.J., Brook M., Morrice N., Snelgrove R., Begum S., Lanfrancotti A.,
RA   Notley C., Hussell T., Cope A.P., Wait R.;
RT   "Themis2/ICB1 is a signaling scaffold that selectively regulates macrophage
RT   Toll-like receptor signaling and cytokine production.";
RL   PLoS ONE 5:E11465-E11465(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-593, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: May constitute a control point in macrophage inflammatory
CC       response, promoting LPS-induced TLR4-mediated TNF production
CC       (PubMed:20644716). Determines the threshold for activation of B cells
CC       by low-affinity and low-avidity ligands via PLCG2 activation and its
CC       downstream pathways (By similarity). {ECO:0000250|UniProtKB:Q91YX0,
CC       ECO:0000269|PubMed:20644716}.
CC   -!- SUBUNIT: Interacts with VAV1. Interacts with LAT. Interacts
CC       constitutively with GRB2, LYN and PLCG2; these interactions increase
CC       the activation of PLCG2 and its downstream pathways following B cell
CC       receptor stimulation. {ECO:0000250|UniProtKB:Q91YX0}.
CC   -!- INTERACTION:
CC       Q5TEJ8; Q7Z3S9: NOTCH2NLA; NbExp=4; IntAct=EBI-2806032, EBI-945833;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q91YX0}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q91YX0}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q5TEJ8-1; Sequence=Displayed;
CC       Name=2; Synonyms=ICB1-beta;
CC         IsoId=Q5TEJ8-2; Sequence=VSP_015326, VSP_015327;
CC       Name=3; Synonyms=ICB1-gamma;
CC         IsoId=Q5TEJ8-3; Sequence=VSP_015330;
CC       Name=4;
CC         IsoId=Q5TEJ8-4; Sequence=VSP_015328, VSP_015329;
CC       Name=5;
CC         IsoId=Q5TEJ8-5; Sequence=VSP_037967;
CC       Name=6;
CC         IsoId=Q5TEJ8-6; Sequence=VSP_037966;
CC   -!- TISSUE SPECIFICITY: Expressed in different endometrial adenocarcinoma
CC       cell lines and various other cell lines apart from the prostate cell
CC       line LNCaP and the ovarian cancer cell line BG1.
CC       {ECO:0000269|PubMed:9563507}.
CC   -!- INDUCTION: By contact to a reconstituted basement membrane.
CC   -!- PTM: Phosphorylation at Tyr-632 is induced by LPS. Phosphorylated by
CC       Src kinases (Lck or Fyn) following BCR engagement.
CC       {ECO:0000250|UniProtKB:Q91YX0}.
CC   -!- SIMILARITY: Belongs to the themis family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC16284.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA96464.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB33313.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG64201.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAI21769.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI21771.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI21773.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR749321; CAH18176.1; -; mRNA.
DR   EMBL; AK303090; BAG64201.1; ALT_INIT; mRNA.
DR   EMBL; AK303141; BAG64245.1; -; mRNA.
DR   EMBL; AL109927; CAI21769.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL109927; CAI21770.1; -; Genomic_DNA.
DR   EMBL; AL109927; CAI21771.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL109927; CAI21772.1; -; Genomic_DNA.
DR   EMBL; AL109927; CAI21773.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC031655; AAH31655.2; -; mRNA.
DR   EMBL; BC132692; AAI32693.1; -; mRNA.
DR   EMBL; BC133049; AAI33050.1; -; mRNA.
DR   EMBL; AF044895; AAC16284.1; ALT_FRAME; mRNA.
DR   EMBL; AB050854; BAB33313.1; ALT_INIT; mRNA.
DR   EMBL; AB035482; BAA96464.1; ALT_INIT; mRNA.
DR   CCDS; CCDS30653.1; -. [Q5TEJ8-2]
DR   CCDS; CCDS30654.1; -. [Q5TEJ8-4]
DR   CCDS; CCDS41290.1; -. [Q5TEJ8-1]
DR   CCDS; CCDS65461.1; -. [Q5TEJ8-5]
DR   RefSeq; NP_001034566.1; NM_001039477.2. [Q5TEJ8-4]
DR   RefSeq; NP_001099026.1; NM_001105556.2. [Q5TEJ8-1]
DR   RefSeq; NP_001273042.1; NM_001286113.1. [Q5TEJ8-5]
DR   RefSeq; NP_001273044.1; NM_001286115.1. [Q5TEJ8-6]
DR   RefSeq; NP_004839.2; NM_004848.3. [Q5TEJ8-2]
DR   RefSeq; XP_006711113.1; XM_006711050.1. [Q5TEJ8-3]
DR   AlphaFoldDB; Q5TEJ8; -.
DR   BioGRID; 114858; 3.
DR   IntAct; Q5TEJ8; 5.
DR   STRING; 9606.ENSP00000363031; -.
DR   iPTMnet; Q5TEJ8; -.
DR   PhosphoSitePlus; Q5TEJ8; -.
DR   BioMuta; THEMIS2; -.
DR   DMDM; 73920021; -.
DR   EPD; Q5TEJ8; -.
DR   jPOST; Q5TEJ8; -.
DR   MassIVE; Q5TEJ8; -.
DR   MaxQB; Q5TEJ8; -.
DR   PaxDb; Q5TEJ8; -.
DR   PeptideAtlas; Q5TEJ8; -.
DR   PRIDE; Q5TEJ8; -.
DR   ProteomicsDB; 65054; -. [Q5TEJ8-1]
DR   ProteomicsDB; 65055; -. [Q5TEJ8-2]
DR   ProteomicsDB; 65056; -. [Q5TEJ8-3]
DR   ProteomicsDB; 65057; -. [Q5TEJ8-4]
DR   ProteomicsDB; 65058; -. [Q5TEJ8-5]
DR   ProteomicsDB; 65059; -. [Q5TEJ8-6]
DR   Antibodypedia; 30867; 107 antibodies from 21 providers.
DR   DNASU; 9473; -.
DR   Ensembl; ENST00000328928.11; ENSP00000329862.7; ENSG00000130775.16. [Q5TEJ8-5]
DR   Ensembl; ENST00000373921.8; ENSP00000363031.3; ENSG00000130775.16. [Q5TEJ8-1]
DR   Ensembl; ENST00000373925.5; ENSP00000363035.1; ENSG00000130775.16. [Q5TEJ8-2]
DR   Ensembl; ENST00000373927.7; ENSP00000363037.3; ENSG00000130775.16. [Q5TEJ8-4]
DR   GeneID; 9473; -.
DR   KEGG; hsa:9473; -.
DR   MANE-Select; ENST00000373921.8; ENSP00000363031.3; NM_001105556.3; NP_001099026.1.
DR   UCSC; uc001boz.5; human. [Q5TEJ8-1]
DR   CTD; 9473; -.
DR   DisGeNET; 9473; -.
DR   GeneCards; THEMIS2; -.
DR   HGNC; HGNC:16839; THEMIS2.
DR   HPA; ENSG00000130775; Tissue enhanced (bone marrow, lymphoid tissue).
DR   MIM; 617856; gene.
DR   neXtProt; NX_Q5TEJ8; -.
DR   OpenTargets; ENSG00000130775; -.
DR   PharmGKB; PA128394550; -.
DR   VEuPathDB; HostDB:ENSG00000130775; -.
DR   eggNOG; ENOG502QSJR; Eukaryota.
DR   GeneTree; ENSGT00530000063770; -.
DR   HOGENOM; CLU_1069427_0_0_1; -.
DR   InParanoid; Q5TEJ8; -.
DR   OMA; DASHPAD; -.
DR   OrthoDB; 337909at2759; -.
DR   PhylomeDB; Q5TEJ8; -.
DR   TreeFam; TF333479; -.
DR   PathwayCommons; Q5TEJ8; -.
DR   SignaLink; Q5TEJ8; -.
DR   BioGRID-ORCS; 9473; 17 hits in 1079 CRISPR screens.
DR   ChiTaRS; THEMIS2; human.
DR   GenomeRNAi; 9473; -.
DR   Pharos; Q5TEJ8; Tbio.
DR   PRO; PR:Q5TEJ8; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5TEJ8; protein.
DR   Bgee; ENSG00000130775; Expressed in monocyte and 158 other tissues.
DR   ExpressionAtlas; Q5TEJ8; baseline and differential.
DR   Genevisible; Q5TEJ8; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0050864; P:regulation of B cell activation; ISS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IBA:GO_Central.
DR   InterPro; IPR025946; CABIT_dom.
DR   InterPro; IPR039671; THEMIS.
DR   PANTHER; PTHR15215; PTHR15215; 1.
DR   Pfam; PF12736; CABIT; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Immunity; Inflammatory response; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..643
FT                   /note="Protein THEMIS2"
FT                   /id="PRO_0000084143"
FT   REGION          1..238
FT                   /note="CABIT 1"
FT   REGION          239..514
FT                   /note="CABIT 2"
FT   REGION          546..631
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         593
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         632
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YX0"
FT   VAR_SEQ         79..123
FT                   /note="GYFTPLNTPQSYETLEELVSATTQSSKQLPTCFMSTHRIVTEGRV -> VFS
FT                   SLRIAATRSAAQTQGEDLARVHQGWLQYVQQDSCPQEGPQAR (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_015328"
FT   VAR_SEQ         124..643
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_015329"
FT   VAR_SEQ         186..381
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037966"
FT   VAR_SEQ         216..260
FT                   /note="MRRTIVKIPSTLEVDVEDVTASSRHVHFIKPLLLSEVLAWEGPFP -> IFS
FT                   SLRIAATRSAAQTQGEDLARVHQGWLQYVQQDSCPQEGPQAR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.6"
FT                   /id="VSP_015326"
FT   VAR_SEQ         252..396
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_015330"
FT   VAR_SEQ         261..643
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.6"
FT                   /id="VSP_015327"
FT   VAR_SEQ         268..396
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037967"
FT   VARIANT         431
FT                   /note="V -> L (in dbSNP:rs35995543)"
FT                   /id="VAR_051060"
FT   VARIANT         511
FT                   /note="K -> E (in dbSNP:rs3766400)"
FT                   /evidence="ECO:0000269|PubMed:14702039, ECO:0000269|Ref.6"
FT                   /id="VAR_051061"
FT   CONFLICT        451
FT                   /note="L -> M (in Ref. 6; AAC16284)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        466
FT                   /note="T -> N (in Ref. 6; AAC16284)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        504
FT                   /note="W -> R (in Ref. 6; AAC16284)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        538
FT                   /note="R -> C (in Ref. 6; AAC16284)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        584
FT                   /note="A -> V (in Ref. 6; AAC16284)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   643 AA;  72049 MW;  1D5FA24F88D2F8EA CRC64;
     MEPVPLQDFV RALDPASLPR VLRVCSGVYF EGSIYEISGN ECCLSTGDLI KVTQVRLQKV
     VCENPKTSQT MELAPNFQGY FTPLNTPQSY ETLEELVSAT TQSSKQLPTC FMSTHRIVTE
     GRVVTEDQLL MLEAVVMHLG IRSARCVLGM EGQQVILHLP LSQKGPFWTW EPSAPRTLLQ
     VLQDPALKDL VLTCPTLPWH SLILRPQYEI QAIMHMRRTI VKIPSTLEVD VEDVTASSRH
     VHFIKPLLLS EVLAWEGPFP LSMEILEVPE GRPIFLSPWV GSLQKGQRLC VYGLASPPWR
     VLASSKGRKV PRHFLVSGGY QGKLRRRPRE FPTAYDLLGA FQPGRPLRVV ATKDCEGERE
     ENPEFTSLAV GDRLEVLGPG QAHGAQGSDV DVLVCQRLSD QAGEDEEEEC KEEAESPERV
     LLPFHFPGSF VEEMSDSRRY SLADLTAQFS LPCEVKVVAK DTSHPTDPLT SFLGLRLEEK
     ITEPFLVVSL DSEPGMCFEI PPRWLDLTVV KAKGQPDLPE GSLPIATVEE LTDTFYYRLR
     KLPACEIQAP PPRPPKNQGL SKQRRHSSEG GVKSSQVLGL QQHARLPKPK AKTLPEFIKD
     GSSTYSKIPA HRKGHRPAKP QRQDLDDDEH DYEEILEQFQ KTI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024